Neuraceq 300 MBq/ml
As listed in the register: Neuraceq 300 MBq/ml, Injektionslösung
·
- Prescription only
- Everything that fits nowhere else, such as contrast media
- Active substance
- Florbetabenum(18-F)
- Made by
- SWAN Isotopen AG SWAN Haus, Inselspital
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Alzheimer-Diagnose: PET-Darstellung zur Dichte von beta-Amyloid-Plaques
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | SWAN Isotopen AG SWAN Haus, Inselspital |
|---|---|
| Active substance | Florbetabenum(18-F) |
| Used in | Everything that fits nowhere else, such as contrast media |
| Classification | V09AX06 · Everything that fits nowhere else, such as contrast media |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Neuraceq 300 MBq/ml, Injektionslösung |
| Packs | 1 Durchstechflasche(n) |
| Zulassungsnummer | 66210 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.